Overview A Single Dose Safety, Tolerability, Pharmacokinetic and Food Effect Study of KVD900 in Healthy Volunteers Status: Completed Trial end date: 2018-09-10 Target enrollment: Participant gender: Summary A safety, tolerability, pharmacokinetic and food effect study of KVD900 in healthy volunteers. Phase: Phase 1 Details Lead Sponsor: KalVista Pharmaceuticals, Ltd.